A road map toward a globally harmonized approach for occupational health surveillance and epidemiology in nanomaterial workers

Journal of Occupational and Environmental Medicine

Volumn 54, Issue 10, 2012, Pages 1214-1223

  Riediker, Michael ^a   Schubauer Berigan, Mary K ^b   Brouwer, Derk H ^c   Nelissen, Inge ^d   Koppen, Gudrun ^d   Frijns, Evelien ^d   Clark, Katherine A ^a   Hoeck, Juergen ^e   Liou, Saou Hsing ^f   Ho, Sweet Far ^g   Bergamaschi, Enrico ^h   Gibson, Rosemary ⁱ  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c TNO   (Netherlands)

^d FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

^e TEMAS AG   (Switzerland)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^g Ministry of Manpower Government of Singapore   (Singapore)

^h UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

ⁱ HEALTH AND SAFETY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NANOMATERIAL;

ARTICLE; COST; CULTURAL ANTHROPOLOGY; DATA BASE; DEATH; ETHICS; HEALTH STATUS; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; NANOTECHNOLOGY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; QUALITATIVE ANALYSIS; REGISTER; WORK ENVIRONMENT; WORKER;

EPIDEMIOLOGICAL MONITORING; HEALTH SURVEYS; HUMANS; NANOSTRUCTURES; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH;

EID: 84867581373     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31826e27f1     Document Type: Article

References (76)

1. Schmid K, Danuser B, Riediker M. Nanoparticle usage and protection measures in the manufacturing industry - a representative survey. J Occup Environ Hyg. 2010;7:224-232.
2. Invernizzi N. Nanotechnology between the lab and the shop floor: what are the effects on labor? J Nanopart Res. 2011;13:2244-2268.
3. Schulte PA, Trout DB. Nanomaterials and worker health: medical surveillance, exposure registries, and epidemiologic research. J Occup Environ Med. 2011;53:S3-S7.
4. Riediker M, Katalagarianakis G, eds. Compendium of Projects in the European NanoSafety Cluster - 2012 Edition. Lausanne, Switzerland: Institute for Work and Health; 2012.
5. Merget R, Bauer T, Kupper HU, et al. Health hazards due to the inhalation of amorphous silica. Arch Toxicol. 2002;75:625-634.
6. Gardiner K, van Tongeren M, Harrington M. Respiratory health effects from exposure to carbon black: results of the phase 2 and 3 cross sectional studies in the European carbon black manufacturing industry. Occup Environ Med. 2001;58:496-503.
7. Schubauer-Berigan MK, Dahm MM, Yencken MS. Engineered carbonaceous nanomaterials manufacturers in the United States: workforce size, characteristics, and feasibility of epidemiologic studies. J Occup Environ Med. 2011;53:S62-S67.
8. Schulte PA, Schubauer-Berigan MK, Mayweather C, Geraci CL, Zumwalde R, McKernan JL. Issues in the development of epidemiologic studies of workers exposed to engineered nanoparticles. J Occup Environ Med. 2009;51:323-335.
9. Laney AS, McCauley LA, Schubauer-Berigan MK. Workshop summary: epidemiologic design strategies for studies of nanomaterial workers. J Occup Environ Med. 2011;53:S87-S90.
10. Boutou-Kempf O, Marchand JL, Radauceanu A, Witschger O, Imbernon E; Group Health Risks of Nanotechnologies. Development of a French epidemiological surveillance system of workers producing or handling engineered nanomaterials in the workplace. J Occup Environ Med. 2011;53:S103-S107.
11. Gibson RM, Adisesh A, Bergamaschi E, et al. Strategies for Assessing Occupational Health Effects of Engineered Nanomaterials. NanoImpactNet Report. Lausanne, Switzerland: Institute for Work and Health; 2010.
12. Schulte PA, Trout DB, Hodson LL. Introduction to the JOEM supplement nanomaterials and worker health: medical surveillance, exposure registries, and epidemiologic research. J Occup Environ Med. 2011;53:S1-S2.
13. Schulte PA, Mundt DJ, Nasterlack M, Mulloy KB, Mundt KA. Exposure registries: overview and utility for nanomaterial workers. J Occup Environ Med. 2011;53:S42-S47.
14. Maynard AD, Aitken RJ. Assessing exposure to airborne nanomaterials: current abilities and future requirements. Nanotoxicology. 2007;1:26-41.
15. HSE Books. Risk Management of Carbon Nanotubes. Sudbury, UK: HSE Books; 2009.
16. Schmid K, Riediker M. Use of nanoparticles in Swiss industry: a targeted survey. Environ Sci Technol. 2008;42:2253-2260.
17. Aitken RJ, Chaudhry MQ, Boxall ABA, Hull M. Manufacture and use of nanomaterials: current status in the UK and global trends. Occup Med. 2006;56:300-306.
18. Balas F, Arruebo M, Urrutia J, Santamaria J. Reported nanosafety practices in research laboratories worldwide. Nat Nanotechnol. 2010;5:93-96.
19. Groso A, Petri-Fink A, Magrez A, Riediker M, Meyer T. Management of nanomaterials safety in research environment. Part Fibre Toxicol. 2010;7:40.
20. Brouwer D. Exposure to manufactured nanoparticles in different workplaces. Toxicology. 2010;269:120-127.
21. Kuhlbusch TAJ, Asbach C, Fissan H, Göhler D, Stintz M. Nanoparticle exposure at nanotechnology workplaces: a review. Part Fibre Toxicol. 2011;8:22.
22. Brouwer D, van Duuren-Stuurman B, Berges M, Jankowska E, Bard D, Mark D. From workplace air measurement results toward estimates of exposure? Development of a strategy to assess exposure to manufactured nano-objects. J Nanopart Res. 2009;11:1867-1881.
23. Brouwer D, Berges M, Virji MA, et al. Harmonization of measurement strategies for exposure to manufactured nano-objects: report of a workshop. Ann Occup Hyg. 2012;56:1-9.
24. Methner M, Hodson L, Dames A, Geraci C. Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials - part B: results from 12 field studies. J Occup Environ Hyg. 2009;7:163-176.
25. Methner M, Hodson L, Geraci C. Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials - part A. J Occup Environ Hyg. 2009;7:127-132.
26. Birch ME, Ku BK, Evans DE, Ruda-Eberenz TA. Exposure and emissions monitoring during carbon nanofiber production - part I: elemental carbon and iron-soot aerosols. Ann Occup Hyg. 2011;55:1016-1036.
27. Dahm MM, Evans DE, Schubauer-Berigan MK, Birch ME, Fernback JE. Occupational exposure assessment in carbon nanotube and nanofiber primary and secondary manufacturers. Ann Occup Hyg. 2012;56:542-556.
28. Schneider T, Brouwer DH, Koponen IK, et al. Conceptual model for assessment of inhalation exposure to manufactured nanoparticles. J Expos Sci Environ Epidemiol. 2011;21:450-463.
29. Jensen H, Pedersen JH, Jorgensen JE, et al. Determination of size distributions in nanosized powders by TEM, XRD, and SAXS. J Exp Nanosci. 2006;1:355-373.
30. Schmid K, Danuser B, Riediker M. A low number of Swiss companies uses nanoparticles. Swiss Med Wkly. 2009;139:18S.
31. Donaldson K, Murphy F, Duffin R, Poland C. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol. 2010;7:5.
32. Schulte PA, Kuempel ED, Zumwalde RD, et al. Focused actions to protect carbon nanotube workers. Am J Ind Med. 2012;55:395-411.
33. Hunt G, Riediker M. Building expert consensus on problems of uncertainty and complexity in nanomaterials safety. Nanotechnol Percept. 2011;7:82-98.
34. Organisation for Economic Co-operation and Development. List of Manufactured Nanomaterials and List of Endpoints for Phase One of the Sponsorship Programme for the Testing of Manufactured Nanomaterials: Revision. Paris, France: Organisation for Economic Co-operation and Development OECD; 2010.
35. Bouwmeester H, Lynch I, Marvin HJP, et al. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology. 2011;5:1-11.
36. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823-839.
37. Kreyling WG, Semmler M, Erbe F, et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A. 2002;65:1513-1530.
38. Oberdorster G, Sharp Z, Atudorei V, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol. 2004;16:437-445.
39. Oberdorster G, Sharp Z, Atudorei V, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A. 2002;65:1531-1543.
40. Riediker M, Cascio WE, Griggs TR, et al. Particulate matter exposure in cars is associated with cardiovascular effects in healthy, young men. Am J Respir Crit Care Med. 2004;169:934-940.
41. Moller P, Loft S. Oxidative damage to DNA and lipids as biomarkers of exposure to air pollution. Environ Health Perspect. 2010;118:1126-1136.
42. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622-627.
43. Poland CA, Duffin R, Kinloch I, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008;3:423-428.
44. Takagi A, Hirose A, Nishimura T, et al. Induction of mesothelioma in p53+/-mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci. 2008;33:105-116.
45. Shvedova AA, Kisin ER, Mercer R, et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol. 2005;289:L698-L708.
46. Gwinn MR, Vallyathan V. Nanoparticles: health effects - pros and cons. Environ Health Perspect. 2006;114:1818-1825.
47. Brook RD, Rajagopalan S, Pope CA III, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-2378.
48. Li N, Nel AE. Feasibility of biomarker studies for engineered nanoparticles: what can be learned from air pollution research. J Occup Environ Med. 2011;53:S74-S79.
49. Suva. Grenzwerte am Arbeitsplatz 2011 [Occupational exposure limits 2011]. Lucerne, Switzerland: Suva; 2011.
50. National Institute for Occupational Safety and Health. Draft Intelligence Bulletin Occupational Exposure to Carbon Nanotubes and Nanofibers. Cincinnati, OH: US Department of Health and Human Services, Centers for Disease Control, National Institute for Occupational Safety and Health; 2010.
51. Antonini JM, Lewis AB, Roberts JR, Whaley DA. Pulmonary effects of welding fumes: review of worker and experimental animal studies. Am J Ind Med. 2003;43:350-360.
52. Liou S-H, Lin M-H, Hsu C-H, et al. The pilot study of specific biomarkers in health effects among engineered nanoparticles manufacturing workers. Epidemiology. 2011;22:S254-S255.
53. Song Y, Li X, Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J. 2009;34:559-567.
54. Erdely A, Hulderman T, Salmen R, et al. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett. 2009;9:36-43.
55. Xia T, Li N, Nel AE. Potential health impact of nanoparticles. Annu Rev Public Health. 2009;30:137-150.
56. Bergamaschi E, Magrini A. Biomonitoring. In: Fadeel B, Pietroiusti A, Shvedova A, eds. Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health. Amsterdam, the Netherlands: Elsevier; 2012:45-62.
57. Riediker M, Cascio WE, Griggs TR, et al. Health effects in male highway patrol troopers are associated with components of in-vehicle fine particulate matter (PM2.5) attributable to stop-and-go traffic. Am J Respir Crit Care Med. 2004;169:A883.
58. Riediker M, Devlin RB, Griggs TR, et al. Cardiovascular effects in patrol officers are associated with fine particulate matter from brake wear and engine emissions. Part Fibre Toxicol. 2004;1:2.
59. Baccarelli A, Martinelli I, Pegoraro V, et al. Living near major traffic roads and risk of deep vein thrombosis. Circulation. 2009;119:3118-3124.
60. Peters A, von KS, Heier M, et al. Exposure to traffic and the onset of myocardial infarction. N Engl J Med. 2004;351:1721-1730.
61. Lucking AJ, Lundback M, Mills NL, et al. Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J. 2008;29:3043-3051.
62. Leone AM, Gustafsson LE, Francis PL, Persson MG, Wiklund NP, Moncada S. Nitric oxide is present in exhaled breath in humans: direct GC-MS confirmation. Biochem Biophys Res Commun. 1994;201: 883-887.
63. Corradi M, Montuschi P, Donnelly LE, Pesci A, Kharitonov SA, Barnes PJ. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med. 2001;163:854-858.
64. Bergamaschi E. Occupational exposure to nanomaterials: present knowledge and future development. Nanotoxicology. 2009;3:194-201.
65. Fairchild CI, Stampfer JF. Particle concentration in exhaled breath - summary report. Am Ind Hyg Assoc J. 1987;48:948-949.
66. Simeonova PP, Erdely A. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers. Inhal Toxicol. 2009;21(suppl 1):68-73.
67. Franco G. Occupational health practice and exposure to nanoparticles: reconciling scientific evidence, ethical aspects, and legal requirements. Arch Environ Occup Health. 2011;66:236-240.
68. Iversen A, Liddell K, Fear N, Hotopf M, Wessely S. Consent, confidentiality, and the Data Protection Act. BMJ. 2006;332:165-169.
69. Hornung RW, Meinhardt TJ. Quantitative risk assessment of lung cancer in US uranium miners. Health Phys. 1987;52:417-430.
70. Stayner L, Smith R, Bailer J, et al. Exposure-response analysis of risk of respiratory disease associated with occupational exposure to chrysotile asbestos. Occup Environ Med. 1997;54:646-652.
71. Nasterlack M, Zober A, Oberlinner C. Considerations on occupational medical surveillance in employees handling nanoparticles. Int Arch Occup Environ Health. 2008;81:721-726.
72. National Institute for Occupational Safety and Health. Interim Guidance for Medical Screening and Hazard Surveillance for Workers Potentially Exposed to Engineered Nanoparticles. DHHS (NIOSH) Publication No. 2009-116. Cincinnati, OH: National Institute for Occupational Safety and Health; 2009.
73. Iavicoli S, Rondinone BM, Boccuni F. Occupational safety and health's role in sustainable, responsible nanotechnology: gaps and needs. Hum Exp Toxicol. 2009;28:433-443.
74. National Institute for Occupational Safety and Health. Exposure assessment and characterization. Approaches to Safe Nanotechnology: Managing the Health and Safety Concerns Associated With Engineered Nanomaterials. Cincinnati, OH: National Institute for Occupational Safety and Health; 2009:23-33.
75. Schulte P, Geraci C, Zumwalde R, Hoover M, Kuempel E. Occupational risk management of engineered nanoparticles. J Occup Environ Hyg. 2008;5:239-249.
76. Gibson RM, Stacey N, Drais E, Wallin H, Zatorski W. Risk Perception and Risk Communication With Regard to Nanomaterials in the Workplace. Luxembourg: European Agency for Safety and Health at Work; 2012.